Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.

Med Sci Monit · 2019 · PMC6397617 · PMID 30796194

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a clear trendp =0.06so close (0.05 < p ≤ 0.1)

There was a clear trend for worse survival even in patients age 25–40 years in the ZA group ( p =0.06, Figure 4 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.